Send to

Choose Destination
Microvasc Res. 2008 Nov;76(3):139-44. doi: 10.1016/j.mvr.2008.06.004. Epub 2008 Jul 4.

Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation.

Author information

Department of Disease Control and Molecular Epidemiology, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, 1757, Hokkaido 061-0293, Japan.


Osteoprotegerin (OPG) is a decoy receptor for the receptor activator of nuclear factor kappaB ligand (RANKL). However, the role of OPG in the endothelium remains unknown. In this study, we demonstrate that OPG stimulates the proliferation and migration of human microvascular endothelial cells (HMVECs). In addition, we show that treatment with integrin alpha(v)beta(3) or integrin alpha(v)beta(5) blocking antibody inhibits endothelial cell migration. In contrast, treatment with anti-alpha(v)beta(3) antibody or anti-alpha(v)beta(5) antibody alone did not inhibit OPG-induced proliferation. However, OPG-induced proliferation was inhibited when these antibodies were applied simultaneously. Furthermore, OPG evoked activation of extracellular signal-regulated kinase (ERK) 1/2, which has been linked to integrin alpha(v) activity. Taken together, these results suggest that integrins alpha(v)beta(3) and/or alpha(v)beta(5) contribute to endothelial cell proliferation and migration induced by OPG.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center